SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection in associated with thinner melanomas? JAMA. 1999; 281: 640-643.
  • 2
    Richard MA, Grob JJ, Avril MR, et al. Delays in diagnosis and melanoma prognosis, II: the role of doctors. Int J Cancer. 2000; 89: 280-285.
  • 3
    Brady MS, Oliveria SA, Christos PF, et al. Patterns of detection in patients with cutaneous melanoma. Cancer. 2000; 89: 342-347.
  • 4
    Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM. Thin primary cutaneous melanoma: associated detection patterns, lesion characteristics, and patient characteristics. Cancer. 2002; 95: 1562-2568.
  • 5
    Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol. 2005; 53: 393-406.
  • 6
    Carli P, DeGiorgi VD, Palli D, et al. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol. 2003; 139: 607-612.
  • 7
    McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol. 2006; 54: 783-792.
  • 8
    Swetter SM, Johnson TM, Miller DR, Layton CJ, Brooks KR, Geller AC. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol. 2009; 145: 397-404.
  • 9
    Durbec F, Vitry F, Granel-Brocard F, et al. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol. 2010; 146: 240-246.
  • 10
    Lasithiotakis K, Leiter U, Meier F, et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer. 2008; 112: 1795-1804.
  • 11
    Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol. 2006; 142: 1551-1558.
  • 12
    Chamberlain AJ, Fritschi L, Giles GC, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002; 138: 609-614.
  • 13
    Geller AC, Elwood M, Swetter SM, et al. Factors related to the presentation of thin and thick nodular melanoma from a population-base cancer registry in Queensland, Australia. Cancer. 2009; 115: 1318-1327.
  • 14
    Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer. 2000; 89: 271-279.
    Direct Link:
  • 15
    Youl PH, Baade PD, Parekh S, English D, Elwood M, Aitken JF. Association between melanoma thickness, clinical skin examination and socioeconomic status: results of a large population-based study. Int J Cancer. 2010; 128: 2158-2165.
  • 16
    Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner MH. Factors associated with high tumour thickness in patients with melanoma. Br J Dermatol. 2007; 156: 938-944.
  • 17
    Van Durme DJ, Ferrante JM, Pal N, Wathington D, Roetzheim RG, Gonzalez EC. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med. 2000; 9: 606-611.
  • 18
    Ortiz CA, Goodwin JS, Freeman JL. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit. 2005; 11: 163-172.
  • 19
    Zell JA, Cinar P, Mobashar M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008; 26: 66-75.
  • 20
    Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009; 129: 1666-1674.
  • 21
    Pennie ML, Soon SL, Risser JB, Veledar E, Culler SD, Chen SC. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol. 2007; 143: 488-494.
  • 22
    Bergenmar M, Ringbord U, Mansson Brahme E, Brandberg Y. Nodular histogenic type: the most significant factor for thick melanoma: implications for prevention. Melanoma Res. 1998; 8: 403-411.
  • 23
    Crocetti E, Carli P. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur J Dermatol. 2003; 13: 72-75.
  • 24
    Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005; 141: 745-750.
  • 25
    Warycha MA, Christos PJ, Mazumdar M, et al. Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer. 2008; 113: 3341-3348.
  • 26
    Pollitt RA, Geller AC, Brooks DR, Johnson TM, Park ER, Swetter SM. Efficacy of skin self-examination practices for early melanoma detection. Cancer Epidemiol Biomarkers Prev. 2009; 18: 3018-3023.
  • 27
    Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969-1999. JAMA. 2002; 288: 1719-1720.
  • 28
    National Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program. SEER Cancer Statistics Review, 1975-2007 [based on the November 2009 SEER data submission, posted to the SEER web site 2010]. Bethesda, MD: National Cancer Institute; 2010. Available at: http://seer.cancer.gov/csr/1975_2007/. Accessed March 30, 2011.
  • 29
    Cook MB, McGlynn K, Devesa S, Freedman DN, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1-9.
  • 30
    Criscione VD, Weinstock MA. Melanoma thickness trends in the United States, 1988-2006. J Invest Dermtol. 2010; 130: 793-797.
  • 31
    Kleinbaum DG, Kupper LK, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods. 3rd ed. Washington, DC: Brooks/Cole Publishing, 1998.
  • 32
    Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27: 6199-6206.
  • 33
    Joose A, deVries E, Eckel R, et al. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol. 2011; 131: 719-726.
  • 34
    Geller AC, Zhang Z, Sober AJ, et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol. 2003; 48: 34-41.
  • 35
    Miller DR, Geller AC, Wyatt SW, et al. Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol. 1996; 34: 962-970.
  • 36
    National Center for Health Statistics. Health, United States, 2005. With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2005.
  • 37
    Coups EJ, Geller AC, Weinstock MA, Heckman CJ, Manne SL. Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States. Am J Med. 2010; 123: 439-445.
  • 38
    Aitken JF, Elwood M, Baade PD, Youl P, English D. Clinical whole-body skin examination reduced the incidence of thick melanomas. Int J Cancer. 2009; 126: 450-458.
  • 39
    Schneider JS, Moore DH, 2nd Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol. 2008; 58: 741-749.
  • 40
    Berwick M, Begg CB, Fine JA, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self examination. J Natl Cancer Inst. 1996; 88: 17-23.
  • 41
    Andrulonis R, Secrest AM, McGuire S, Geskin LJ, Ferris LK. The influence of age and sex on reasons for seeking and expected benefits of skin cancer screening. Arch Dermatol. 2010; 146: 1097-1102.
  • 42
    Oliveria SA, Heneghan MK, Cushman LF, Ughetta EA, Halpern AC. Skin cancer screening by dermatologists, family practitioners, and internists. Arch Dermatol. 2011; 147: 39-44.
  • 43
    US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Health, United States 2010. DHHS Publ. No. 2011-1232. Hyattsville, MD: US Department of Health and Human Services; 2011.